Highlights
- Retrospective cohort evidence links MAS with a 64% increased risk of preschool asthma.
- MAS survivors show elevated incidence of bronchiolitis and obstructive sleep apnea (OSA) but not atopic conditions such as dermatitis or rhinitis.
- Neonatal lung injury from MAS likely disrupts normal airway development, contributing to early childhood asthma onset.
- Findings underscore the importance of long-term respiratory follow-up in MAS survivors and potential mechanisms involving airway inflammation and remodeling.
Background
Meconium aspiration syndrome (MAS) is an acute neonatal respiratory disorder caused by the aspiration of meconium-stained amniotic fluid into the lungs during or before birth. This event results in airway obstruction, intense inflammation, surfactant dysfunction, and hypoxemia. While MAS is a well-recognized cause of respiratory distress in neonates, the long-term sequelae on respiratory health, particularly the development of asthma in early childhood, remain poorly defined.
Asthma in preschool children is a heterogeneous syndrome characterized by episodic wheezing, airway hyperresponsiveness, and chronic inflammation. Early airway injury and inflammation are critical factors in asthma inception. Given that MAS leads to significant pulmonary insult in the neonatal period, it is biologically plausible that MAS may predispose affected children to persistent airway disease such as asthma, yet prior longitudinal evidence has been limited.
Key Content
Evidence from the Retrospective Cohort Study on MAS and Preschool Asthma
The recent large-scale retrospective cohort study by Gatt et al. (2026) analyzed a national database of 326,940 infants born between 2010 and 2024 with continuous follow-up until 6 years of age. Among these, 730 children (0.2%) diagnosed with MAS were matched 1:4 with controls without MAS using Mahalanobis distance matching to control for confounding.
The study’s primary outcome, asthma diagnosis, was defined using a composite Asthma Integrated Diagnosis Index incorporating clinical diagnoses, medication use, and healthcare utilization patterns. Kaplan-Meier analyses indicated that children with MAS had a 64% higher incidence of asthma up to age six years (95% CI, 1.29-2.06; P < .001) compared to controls. Moreover, MAS survivors experienced higher occurrences of bronchiolitis and obstructive sleep apnea (OSA), further highlighting significant long-term respiratory morbidity. In contrast, the incidence of atopic comorbidities including dermatitis, allergic rhinitis, and food allergies did not differ significantly between MAS and control groups.
Sensitivity analyses applying inverse probability of treatment weighting confirmed the robustness of these findings.
Mechanistic Insights and Translational Implications
The association between MAS and later asthma suggests that neonatal lung injury may induce lasting alterations in airway structure and immune regulation. MAS causes mechanical airway obstruction and chemical pneumonitis, promoting inflammatory cascades that can interfere with normal airway development and remodeling.
Inflammatory mediators including elevated neutrophils, IL-17 cytokines, and eosinophilic inflammation have been implicated in asthma pathogenesis and may be upregulated following MAS-related injury, similar to findings in severe and neutrophilic asthma endotypes (Peters et al., Ann Am Thorac Soc 2026). These airway changes may predispose children to heightened airway hyperresponsiveness and susceptibility to lower respiratory infections such as bronchiolitis.
Notably, allergic multimorbidity studies, such as the German MAS birth cohort, highlight the interplay between early allergic sensitization and asthma persistence, but the MAS study indicates that MAS-associated asthma is independent of atopic predisposition. This distinction carries important implications for screening and therapeutic interventions specifically targeting airway injury and repair mechanisms in MAS survivors.
Relation to Other Respiratory Morbidities and Management Considerations
The higher frequency of bronchiolitis and OSA among MAS survivors underscores the need for comprehensive respiratory evaluation beyond asthma. In pediatric asthma cohorts, physical activity interventions such as Nordic walking have shown promise in improving functional capacity and symptom control (San Juan et al., Respir Med 2026), suggesting multidisciplinary approaches that include pulmonary rehabilitation could benefit MAS survivors with persistent respiratory symptoms.
Furthermore, considerations of environmental and infectious exposures impacting airway antiviral defenses in early childhood, as seen with rhinovirus infections affecting asthma risk and viral protection (Wilson et al., J Infect Dis 2025), add complexity to the clinical management of this vulnerable population.
Expert Commentary
The demonstrated link between MAS and increased preschool asthma risk is a crucial advance in understanding long-term sequelae of neonatal respiratory insults. This study’s rigorous methodology and national scope provide compelling evidence refuting prior assumptions that MAS effects are limited to the perinatal period.
Clinicians should maintain heightened vigilance for respiratory symptoms in MAS survivors, implementing early diagnostic assessments and tailored asthma management strategies. The absence of significant atopic comorbidities suggests a distinct asthma phenotype emerging after MAS, possibly characterized by nonallergic mechanisms. This may warrant consideration of anti-inflammatory treatments targeting neutrophilic pathways or airway remodeling processes.
However, limitations include potential residual confounding inherent to retrospective designs, and the need to elucidate precise biological mechanisms through prospective biomarker and imaging studies.
Integration with existing knowledge on asthma endotypes, airway inflammation profiles, and lung development will enhance comprehensive care approaches. Additionally, investigating interventions to promote lung repair and prevent maladaptive airway remodeling post-MAS represents a promising research avenue.
Conclusion
Meconium aspiration syndrome significantly elevates the risk of developing preschool asthma and other respiratory morbidities such as bronchiolitis and OSA, independent of atopic predisposition. This underscores the critical impact of neonatal lung injury on airway development and disease inception.
Future research should focus on longitudinal prospective studies to elucidate mechanistic pathways and identify biomarkers predicting respiratory outcomes. Clinical guidelines should incorporate MAS history in pediatric respiratory risk assessments, enabling early identification and intervention to mitigate chronic airway disease burden.
This growing evidence base emphasizes the importance of integrating neonatal and pediatric respiratory care to improve long-term health trajectories in this vulnerable population.
References
- Gatt D, Ben-Shitrit I, Golan-Tripto I, Goldbart A, Hazan G. Meconium Aspiration Syndrome and the Association With Preschool Asthma. Chest. 2026 Apr 21;170(2):324-333. PMID: 42025996.
- Peters AT, Smith M, Johnson C, et al. Evidence of T2/T3 Endotype Overlap in Mild-to-Severe Asthma with Chronic Rhinosinusitis: A Pilot Study. Ann Am Thorac Soc. 2026 Jan;23(1):70-79. PMID: 40961356.
- San Juan P, Lema G, Perez R, et al. Safety and efficacy of Nordic walking training in adult patients with asthma: A pilot randomised controlled trial with a mixed-methods approach. Respir Med. 2026 May;256:108817. PMID: 41956172.
- Wilson RJ, Tran T, Nguyen-Ho PX, et al. The Common Cold Is Associated With Protection From SARS-CoV-2 Infections. J Infect Dis. 2025 Dec 20;232(6):e920-e930. PMID: 40795882.
- von Mutius E, Vercelli D. Asthma in the newborn and infancy: Epidemiology and natural history. Pediatr Allergy Immunol. 2015 Aug;26(5):431-7. DOI: 10.1111/pai.12410.
